https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55109 Wed 10 Apr 2024 08:53:58 AEST ]]> Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55638 Tue 11 Jun 2024 18:43:38 AEST ]]> Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51900 Fri 22 Sep 2023 09:29:58 AEST ]]>